Retraining Attention to Treat Alcohol Dependence and Social Anxiety (AMP)
15. desember 2016 oppdatert av: Joshua Magee, University of Cincinnati
Cognitive Bias Modification: A Novel Intervention for Alcohol Dependence and Social Anxiety
The purpose of this research is to test a computerized intervention for people with co-occurring social anxiety and alcohol dependence.
The intervention seeks to reduce symptoms by shifting attention away from alcohol-relevant and/or socially threatening cues.
The investigators expect that participants receiving alcohol or anxiety training will experience reductions in those specific symptoms compared to participants in a control condition.
The investigators also expect that participants receiving combined alcohol and anxiety training will show the largest reductions in alcohol and anxiety symptoms, relative to participants in any other condition.
Studieoversikt
Status
Fullført
Forhold
Detaljert beskrivelse
Alcohol Use Disorders (AUDs) and Social Anxiety Disorder are disabling and chronic conditions.
In spite of these common and significantly overlapping problems, insight into the mechanisms linking alcohol dependence and social anxiety symptoms is minimal, and there are not well established treatment guidelines for this population.
In this study, the investigators seek to develop a computerized intervention for individuals with symptoms of social anxiety and alcohol dependence.
The intervention attempts to reduce symptoms by shifting attention away from alcohol-relevant and/or socially threatening cues.
The investigators expect that participants receiving alcohol or anxiety training will experience reductions in those specific symptoms compared to participants in a control condition.
The investigators also expect that participants receiving combined alcohol and anxiety training will show the largest reductions in alcohol and anxiety symptoms, relative to participants in any other condition.
Studietype
Intervensjonell
Registrering (Faktiske)
115
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Ohio
-
Cincinnati, Ohio, Forente stater, 45206
- University of Cincinnati Department of Family and Community Medicine
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Current alcohol dependence
- Elevated social anxiety symptoms
- Willingness to consider cutting down on drinking
Exclusion Criteria:
- Current psychosis
- Unmanaged manic symptoms
- Significant cognitive impairment
- Other drug use in past month
- Receiving cognitive behavioral therapy for alcohol use disorder or social anxiety
- Unable to read
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Anxiety Attention Training only
Participants will receive Anxiety Attention Training and placebo Alcohol training.
|
Anxiety Attention Training will preferentially direct participants' attention away from reminders of anxiety.
|
|
Eksperimentell: Alcohol Attention Training only
Participants will receive Alcohol Attention Training and placebo Anxiety training.
|
Alcohol Attention Training will preferentially direct participants' attention away from reminders of alcohol.
|
|
Eksperimentell: Anxiety + Alcohol Attention Training
Participants will receive both Anxiety Attention Training and Alcohol Attention Training.
|
Anxiety Attention Training will preferentially direct participants' attention away from reminders of anxiety.
Alcohol Attention Training will preferentially direct participants' attention away from reminders of alcohol.
|
|
Placebo komparator: Control Training
Participants will receive placebo Anxiety Training and placebo Alcohol training.
|
Placebo Anxiety Training and Placebo Alcohol Training will not preferentially direct participants' attention away from reminders of anxiety or alcohol.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Liebowitz Social Anxiety Scale
Tidsramme: Baseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)
|
The experimenter-administered Liebowitz Social Anxiety Scale (Liebowitz, 1987) was the primary measure to assess social anxiety symptoms.
This well-validated instrument assesses fear and avoidance across a range of 24 social and performance situations during the course of the previous week.
A total LSAS score was computed, ranging from 0 (no fear or avoidance) to 144 (the greatest level of fear and avoidance).
|
Baseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)
|
|
The Daily Drinking Questionnaire
Tidsramme: Baseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)
|
The Daily Drinking Questionnaire (Collins, Parks, & Marlatt, 1985) was the primary measure used to assess weekly alcohol consumption.
This calendar-based measure was administered by the experimenter once per week to monitor changes in symptoms.
The measure assessed the total number of drinks in the past week.
|
Baseline, weekly throughout the 4-week trial, and in the follow-up sessions (1 week and 1 month follow-ups)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Joshua C Magee, Ph.D., University of Cincinnati
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. juli 2013
Primær fullføring (Faktiske)
1. desember 2014
Studiet fullført (Faktiske)
1. desember 2014
Datoer for studieregistrering
Først innsendt
17. juni 2013
Først innsendt som oppfylte QC-kriteriene
21. juni 2013
Først lagt ut (Anslag)
26. juni 2013
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
28. desember 2016
Siste oppdatering sendt inn som oppfylte QC-kriteriene
15. desember 2016
Sist bekreftet
1. desember 2016
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 1R21AA021151 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .